Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | AKR1C3 | P42330 | 6/20 | 0.54 |
| ▸ | AKR1C2 | P52895 | 5/20 | 0.54 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MME | P08473 | 1/20 | 0.46 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | CPA1 | P15085 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | GLI1 | P08151 | 1/20 | 0.46 |
| ▸ | GLI2 | P10070 | 1/20 | 0.46 |
| ▸ | HTR1D | P28221 | 1/20 | 0.46 |
| ▸ | HTR1B | P28222 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28575917 | 0.88 | PTGS1 (0.56) | PTGS1MEN1CYP2D6KMT2AAKR1C3 | |
| SCHEMBL2020322 | 0.87 | AKR1C3 (0.70) | PTGS1AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL11537584 | 0.87 | PTGS1 (0.55) | PTGS1MEN1CYP2D6KMT2AALOX5 | |
| SCHEMBL14280733 | 0.87 | PTGS1 (0.51) | PTGS1MEN1CYP2D6KMT2AAKR1C3 | |
| SCHEMBL6649963 | 0.86 | PTGS1 (0.51) | PTGS1MEN1CYP2D6KMT2AAKR1C3 | |
| Water SCHEMBL11762224 | 0.86 | PTGS1 (0.54) | PTGS1MEN1CYP2D6KMT2AAKR1C3 | |
| Water SCHEMBL11762220 | 0.86 | PTGS1 (0.54) | PTGS1MEN1CYP2D6KMT2AAKR1C3 | |
| SCHEMBL30371750 | 0.85 | PTGS1 (0.64) | PTGS1MEN1CYP2D6KMT2AAKR1C3 | |
| SCHEMBL7380424 | 0.84 | PTGS1 (0.68) | PTGS1MEN1CYP2D6KMT2AAKR1C3 | |
| SCHEMBL11157909 | 0.84 | AKR1C3 (0.53) | PTGS1AKR1C3AKR1C2AKR1C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7332516-B2 | Geminally di-substituted NSAID derivatives as Aβ42 lowering agents | MERCK + CO., INC. (US) | 2008-02-19 | — | — | US | disclosed |
| EP-1587798-A4 | GEMINALLY DI-SUBSTITUTED NSAID DERIVATIVES AS ABETA 42 LOWERING AGENTS | MERCK & CO INC (US) | 2007-06-27 | — | — | EP | disclosed |
| US-20060063937-A1 | Geminallyl di-substituted nsaid derivatives as abeta 42 lowering agents | MERCK SHARP & DOHME CORP. | 2006-03-23 | — | — | US | disclosed |
| EP-1587798-A2 | GEMINALLY DI-SUBSTITUTED NSAID DERIVATIVES AS ABETA 42 LOWERING AGENTS | Merck & Co., Inc. (US) | 2005-10-26 | — | — | EP | disclosed |
| WO-2004064771-A2 | GEMINALLY DI-SUBSTITUTED NSAID DERIVATIVES AS ABETA 42 LOWERING AGENTS | MERCK & CO., INC. (US) | 2004-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060063937-A1 | Geminallyl di-substituted nsaid derivatives as abeta 42 lowering agents | APP, PSEN1, CA1 | PTGS1 20/4885MEN1 1296/4885CYP2D6 690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.